Blue Print of life

By Christopher Hogue, PhD and Randall C. Willis In fields ranging from medicine and biotechnology to agriculture and the environment, the genomics revolution of the past decade is slowly giving way to a systems-wide approach to solving biological questions, as Read more…

Challenge Business

With the bear market for venture capital a seemingly permanent fixture of the investment landscape, it is critical for the fortunate few biotechnology companies that have secured a meeting with a venture capital firm to present their businesses’ value propositions Read more…

Therapure Biopharma

By Shawn Lawrence A new Canadian biopharmaceutical company with past ties to a now defunct company is launching itself with a new focus. On September 2, 2008, the remnants of Hemosol Corporation, a company and facility which went into receivership Read more…

Protex Therapeutics Inc Vancouver BC

Therapeutic vaccines present an attractive alternative to conventional treatments for cancer. However, tumors have evolved various immune evasion mechanisms to modulate innate, adaptive, and regulatory immunity for survival. Therefore, successful vaccine formulations may require a non-toxic immunomodulator or adjuvant that Read more…

Infection Autoimmune Disease

The relatively new technology of DNA microarrays has made it feasible to measure the expression levels of thousands of genes in small biological samples. It has been suggested that this methodology might be especially useful in analyzing the complex and Read more…

Autoimmune Disease

The battle against microbial pathogens and infectious diseases has just received a $17-million boost courtesy of Genome Canada (Ottawa, ON) and Genome BC (Vancouver, BC). The Pathogenomics of Innate Immunity (PI2) project — an international collaboration between researchers in British Read more…

Raising goats

Nexia Biotechnologies CEO Jeffrey Turner, PhD is working on something big BY PATRICIA NICHOLSON Raising goats in Quebec may not sound like a wildly ambitious plan — unless it’s Jeffrey Turner’s plan. Turner, PhD, is president and CEO of Nexia Read more…

CESE Plus A Computational Approach For Accelerating Electrophysiology Research

CESE is an integrated environment for performing computational simulations using a variety of electrophysiological models. At this stage CESE allows creation and execution of the single-cell models (containing both Hodgkin-Huxley (HH) and Markovian current formulations). Models of electrical activity of Read more…

Ambitious Biopharma

By Patricia Nicholson Francesco Bellini, PhD has already left an imposing legacy in Canadian life science. He was co-founder, chairman and CEO of one of Canada’s most successful biotech companies, BioChem Pharma Inc. He was a driving force behind the Read more…

Biopolis Quebec

BiopolisQuébec, the alliance of leading life sciences regions in the province of Québec (Greater Montréal, Québec and Sherbrooke) dedicated to promoting the expertise of this major sector internationally, is happy to announce that it has signed a memorandum of understanding Read more…

Random Posts